Salt and Structure: Linking Hyponatremia to Cardiac Dysfunction in Critical Heart Failure. [PDF]
Suciadi LP.
europepmc +1 more source
WCN24-2108 IS TOLVAPTAN A PROTECTIVE AGENT FOR CARDIAC INSUFFICIENCY IN PERITONEAL DIALYSIS PATIENTS?A METAANALYSIS [PDF]
Stylianou Konstantinos +1 more
openalex +1 more source
Tolvaptan-Loaded Tomato-Derived Nanovesicles: Characterization and Evaluation of Cytotoxicity, Wound Healing Potential and the Effects on Cyst Formation in Renal Cell Lines. [PDF]
Mammadova R +8 more
europepmc +1 more source
Response to the Letter to the Editor Entitled "Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes". [PDF]
Dahl NK, Torres VE.
europepmc +1 more source
Coincidence of autosomal dominant polycystic kidney disease and Alport syndrome: a case report and literature review. [PDF]
Liu R, Liu F.
europepmc +1 more source
Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experience. [PDF]
Econimo L +14 more
europepmc +1 more source
Preventive Effect of Tolvaptan on Pleural Effusion after Cardiac Valvular Surgery
Atsushi Aoki +4 more
openalex +2 more sources
Do I really need to be admitted? A case for more outpatient therapies for acute decompensated heart failure. [PDF]
Hajduczok AG, Sauer AJ, Wettersten N.
europepmc +1 more source
Decoding Hyponatremia: A Systematic Review of Diagnostic Pathways and Therapeutic Approaches Applied When Correction Fails. [PDF]
Kaur K +9 more
europepmc +1 more source

